Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $735.78 | 9 | 87.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $83.39 | 1 | 9.9% |
| Education | $26.08 | 3 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $445.25 | 5 | $0 (2019) |
| Allergan Inc. | $126.00 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.06 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $116.59 | 1 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $20.89 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $13.46 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $361.86 | 4 | United Therapeutics Corporation ($361.86) |
| 2018 | $209.39 | 2 | Allergan Inc. ($126.00) |
| 2017 | $274.00 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($123.06) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2019 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 07/18/2019 | United Therapeutics Corporation | REMODULIN (Drug), TYVASO, NONE | Food and Beverage | In-kind items and services | $207.13 | General |
| Category: PAH | ||||||
| 07/18/2019 | United Therapeutics Corporation | REMODULIN (Drug), TYVASO, NONE | Food and Beverage | In-kind items and services | $110.90 | General |
| Category: PAH | ||||||
| 07/18/2019 | United Therapeutics Corporation | REMODULIN (Drug), TYVASO, NONE | Food and Beverage | In-kind items and services | $41.33 | General |
| Category: PAH | ||||||
| 09/13/2018 | United Therapeutics Corporation | NONE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $83.39 | General |
| Category: NON-BRANDEDDISEASE STATE | ||||||
| 07/25/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $126.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2017 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Drug) | Food and Beverage | In-kind items and services | $116.59 | General |
| Category: Respiratory | ||||||
| 08/09/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Education | In-kind items and services | $20.89 | General |
| Category: Cardio-pulmonary | ||||||
| 01/11/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 251 | 255 | $31,222 | $10,659 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 31 | 31 | $12,059 | $4,638 | 38.5% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 44 | 44 | $4,814 | $1,553 | 32.3% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 32 | 32 | $3,464 | $1,117 | 32.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 48 | 49 | $3,211 | $955.97 | 29.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 12 | $2,424 | $900.57 | 37.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 26 | 26 | $3,075 | $874.84 | 28.5% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 22 | 24 | $1,210 | $289.85 | 24.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 13 | 13 | $377.00 | $131.20 | 34.8% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2020 | 12 | 12 | $336.00 | $114.55 | 34.1% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 12 | 12 | $252.00 | $84.62 | 33.6% |
About Dr. Michael Witte, DO
Dr. Michael Witte, DO is a Pulmonary Disease healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619953627.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Witte, DO has received a total of $845.25 in payments from pharmaceutical and medical device companies, with $361.86 received in 2019. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($735.78).
As a Medicare-enrolled provider, Witte has provided services to 251 Medicare beneficiaries, totaling 255 services with total Medicare billing of $10,659. Data is available for 1 year (2020–2020), covering 10 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Des Moines, IA
- Active Since 12/21/2005
- Last Updated 11/11/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1619953627
Products in Payments
- REMODULIN (Drug) $359.36
- AVYCAZ (Drug) $126.00
- OFEV (Drug) $123.06
- CINQAIR (Drug) $116.59
- NONE (Drug) $83.39
- Adempas (Drug) $20.89
- BROVANA (Drug) $10.77
- UTIBRON (Drug) $2.69
- ORENITRAM (Drug) $2.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Des Moines
Shrey Velani, Md, MD
Pulmonary Disease — Payments: $20,485
Bradley Wilcox, Do, DO
Pulmonary Disease — Payments: $7,222
Eric Asbe, Do, DO
Pulmonary Disease — Payments: $4,123
Donald Shumate, D.o, D.O
Pulmonary Disease
Dr. Randall Hanson, M.d, M.D
Pulmonary Disease
Dr. Donald Burrows, Md, MD
Pulmonary Disease